Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers.

Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers.
复制标题

DOI:
10.1016/j.pnpbp.2013.11.001
复制
发表时间:
2014-04-03
影响因子:
5.6
通讯作者:
De La Garza, Richard, II
De La Garza, Richard, II
中科院分区:
医学2区
文献类型:
--
作者:
Mahoney, James J., III;Kalechstein, Ari D.;Verrico, Christopher D.;Arnoudse, Nicholas M.;Shapiro, Benjamin A.;De La Garza, Richard, II

文献摘要

参考文献

被引文献

相似文献

Long-term cocaine use is a risk factor for the onset of neurocognitive impairment. This study sought to determine whether the cholinesterase inhibitor rivastigmine could improve neurocognitive performance in cocaine-dependent individuals. Cocaine-dependent individuals who were not seeking treatment at the time of enrollment in the study were randomly assigned to receive placebo (n = 16), rivastigmine 3 mg (n = 13), or rivastigmine 6 mg (n = 12). The baseline neurocognitive assessment, which included measures of attention/information processing (as measured by the Continuous Performance Task-II (CPT-II)), verbal learning/episodic memory (as measured by the Hopkins Verbal Learning Test-Revised (HVLT-R)), and working memory (as measured by the Dual N-Back Task), was conducted prior to the administration of study medication (Day 0). The follow-up assessment was conducted on Day 8 after the participants had received rivastigmine or placebo for 7 days (Day 2–8). Rivastigmine administration significantly improved performance on one measure of working memory span (mean n-back span). This study provides additional data showing that cocaine-associated neurocognitive impairment, specifically working memory deficits, can be remediated, at least to some degree.
DOI: 10.1136/jnnp.2006.099424
发表时间: 2007-10-01
影响因子: 11
作者:
Feldman, Howard H.;Lane, Roger
通讯作者: Lane, Roger
DOI: 10.1016/0304-3940(90)90568-t
发表时间: 1990-02-05
影响因子: 2.5
作者:
HURD, YL;WEISS, F;UNGERSTEDT, U
通讯作者: UNGERSTEDT, U
DOI: 10.1016/j.neuropharm.2012.06.064
发表时间: 2013-01-01
期刊: NEUROPHARMACOLOGY
影响因子: 4.7
作者:
Kalechstein, A. D.;Mahoney, J. J., III;De La Garza, R., II
通讯作者: De La Garza, R., II
DOI: 10.1038/npp.2010.18
发表时间: 2010-06-01
影响因子: 7.6
作者:
Adinoff, Bryon;Devous, Michael D., Sr.;Cullum, Munro
通讯作者: Cullum, Munro
DOI: 10.1016/j.drugalcdep.2005.08.003
发表时间: 2006-02-28
影响因子: 4.2
作者:
Aharonovich, E;Hasin, DS;Nunes, EV
通讯作者: Nunes, EV